Instil Bio director granted 6,500 stock options
Instil Bio director Neil W. Gibson received a stock option grant as compensation.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Instil Bio director Neil W. Gibson received a stock option grant as compensation. The award covers 6,500 shares of common stock at an exercise price of $7.93 per share and expires on June 10, 2036. The option vests in 12 monthly installments starting July 11, 2026, with accelerated vesting upon the next annual stockholder meeting, death, disability, or a change in control, if he remains in continuous service.
Insider Trade Summary
Grant/Award: 0 shares
Grant/Award
1 txn
Insider
Gibson Neil W
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 0 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 6,500 contracts (Direct)
Footnotes (1)
- F1. The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).
Key Figures
Option grant size: 6,500 shares
Exercise price: $7.93 per share
Expiration date: June 10, 2036
+2 more
5 metrics
Option grant size
6,500 shares
Underlying common stock for new stock option award
Exercise price
$7.93 per share
Stock option strike price
Expiration date
June 10, 2036
Option term end date
Post-grant derivative holdings
6,500 options
Total options following transaction
Vesting schedule length
12 months
Monthly vesting installments starting July 11, 2026
Key Terms
Stock Option (Right to Buy), Continuous Service, Equity Incentive Plan, Change in Control, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Continuous Service financial
"subject to the Reporting Person's Continuous Service through the vesting dates"
Equity Incentive Plan financial
"as defined in the company's 2021 Equity Incentive Plan, the "Plan""
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Change in Control financial
"will also vest in full in the event of the Reporting Person's death, Disability or upon a Change in Control"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Disability financial
"in the event of the Reporting Person's death, Disability or upon a Change in Control"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Instil Bio (TIL) director Neil W. Gibson receive in this Form 4 filing?
Neil W. Gibson received a stock option grant for 6,500 shares of Instil Bio common stock. The award is a compensation-related grant, not an open-market purchase or sale, and gives him the right to buy shares at a fixed exercise price.
What is the exercise price and term of Neil W. Gibson’s Instil Bio (TIL) stock options?
The granted stock options have an exercise price of $7.93 per share and expire on June 10, 2036. This long-dated option term provides a multi-year window for potential exercise, subject to vesting and continued service conditions described in the grant.
How do Neil W. Gibson’s Instil Bio (TIL) options vest under this grant?
The option vests in 12 substantially equal monthly installments starting July 11, 2026, contingent on continuous service. Any unvested portion will fully vest at the next annual stockholder meeting, or upon death, disability, or a change in control, if service continues to those dates.
Does this Instil Bio (TIL) Form 4 show insider buying or selling in the market?
No, the Form 4 reports a grant of stock options as compensation, coded as an acquisition (A), not an open-market transaction. There are no reported purchases or sales of common stock in the market associated with this filing.
How many Instil Bio (TIL) derivative securities does Neil W. Gibson hold after this grant?
Following the grant, Gibson is reported as holding 6,500 stock options related to Instil Bio common stock. These options represent potential future share ownership if exercised, rather than currently held common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
